trending Market Intelligence /marketintelligence/en/news-insights/trending/uyGbHKOCDRET_44BADyuWg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Sartorius to buy majority stake in Israel's Biological Industries

Banking Essentials Newsletter December Edition Part 2

Banking Essentials Newsletter - November Edition

University Essentials | COVID-19 Economic Outlook in Banking: Rates and Long-Term Expectations: Q&A with the Experts

Estimating Credit Losses Under COVID-19 and the Post-Crisis Recovery


Sartorius to buy majority stake in Israel's Biological Industries

Pharmaceutical equipment supplier Sartorius AG agreed to acquire just over 50% of the shares of Israeli cell culture media company Biological Industries Israel Beit Haemek Ltd. from its owners, Kibbutz Beit Haemek and private equity fund Fortissimo Capital, in a cash transaction worth approximately €45 million.

The deal also includes an option to acquire a further 20% of the shares within three years.

The transaction is set to be finalized by mid-December, subject to customary closing conditions.